Clearside Biomedical, Inc. (CLSDQ) › Capital ExpendituresClearside Biomedical, Inc. (CLSDQ) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2014: $140.0K2015: $32.0K2016: $3.0K2017: $306.0K2018: $88.0K2019: $25.0K2020: $55.0K2021: $02022: $246.0K2023: $1.78M2024: $977.0K$977.0K2014Capital Expenditures (USD)2024Fiscal YearCapital ExpendituresChange YoY2024$977.0K-45.0%2023$1.78M+622.4%2022$246.0K—2021$0-100.0%2020$55.0K+120.0%2019$25.0K-71.6%2018$88.0K-71.2%2017$306.0K+10100.0%2016$3.0K-90.6%2015$32.0K-77.1%2014$140.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share